DE
42
-4
HP
18
-10
NWL
27
-5
QCOM
31
-9
EXPE
48
-11
TRV
31
-18
FLR
30
-10
AMGN
13
-10
DNB
46
-10
PYPL
4
-27
ACN
11
-7
ED
37
-12
MCK
70
-11
MRK
17
-11
OI
24
-9
ESS
28
-12
TXT
25
-8
AFL
45
-14
PG
51
-17
WMB
43
-12
DE
42
-4
HP
18
-10
NWL
27
-5
QCOM
31
-9
EXPE
48
-11
TRV
31
-18
FLR
30
-10
AMGN
13
-10
DNB
46
-10
PYPL
4
-27
ACN
11
-7
ED
37
-12
MCK
70
-11
MRK
17
-11
OI
24
-9
ESS
28
-12
TXT
25
-8
AFL
45
-14
PG
51
-17
WMB
43
-12
Financhill
Back

IGM Biosciences 10K Form

Sell
16

IGMS
IGM Biosciences

Last Price:
$1.12
Seasonality Move:
-6.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGMS News And Ratings

See the #1 stock for the next 7 days that we like better than IGMS

IGMS Financial Statistics

Sales & Book Value

Annual Sales: $2.7M
Cash Flow: $-35.7M
Price / Cash Flow: 0
Annual Sales: $0.81
Price / Book: 1.4

Profitability

EPS (TTM): -3.24000
Net Income (TTM): $-195.8M
Gross Margin: --
Return on Equity: -159.45%
Return on Assets: -57.38%

IGM Biosciences Earnings Forecast

Key IGM Biosciences Financial Ratios

  • The Research & Development expenses have been 6,004.26% of Revenue.
  • The Net Earning history of IGMS is -7,308.51% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

IGM Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IGMS
CUSIP: 449585
Website: igmbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.14
Quick Ratio: 4.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGMS Technical Analysis vs Fundamental Analysis

Sell
16
IGM Biosciences (IGMS) is a Sell

Is IGM Biosciences a Buy or a Sell?

  • IGM Biosciences stock is rated a Sell
    The current IGM Biosciences [IGMS] share price is $1.13. The Score for IGMS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.